Catalyst Pharmaceuticals ... (CPRX)
NASDAQ: CPRX
· Real-Time Price · USD
20.23
0.16 (0.80%)
At close: Aug 15, 2025, 3:59 PM
20.15
-0.37%
After-hours: Aug 15, 2025, 07:54 PM EDT
Catalyst Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 208.66M | 197.35M | 163.89M | 142.8M | 68.15M | 65.12M | 71.41M | 62.04M | 115.55M | 99.41M | 83.08M | 66.92M | 54.5M | 45.06M | 39.48M | 41.61M | 74.62M | 72.22M |
Depreciation & Amortization | 37.83M | 37.87M | 37.84M | 37.53M | 36.65M | 35.71M | 32.88M | 24.35M | 16.34M | 7.8M | 1.24M | 657K | 135K | 129K | 192K | 190.49K | 248.82K | 905.81K |
Stock-Based Compensation | 23.04M | 19.85M | 22.25M | 21.33M | 20.72M | 19.61M | 14.25M | 11.93M | 10.17M | 8.9M | 7.91M | 7.45M | 6.91M | 6.41M | 6.07M | 6.07M | 6.04M | 6.31M |
Other Working Capital | 35.64M | 42.17M | 44.98M | 48.35M | 22.99M | 9.54M | 25.34M | 25.85M | 35.6M | 45.39M | 15.28M | 11.67M | 9.95M | 9.23M | 10.36M | 3.49M | -572.85K | -6.63M |
Other Non-Cash Items | -14.58M | 11.6M | 14.39M | 19.95M | 103.79M | 80.16M | 80.2M | 81.39M | 4.46M | 5.1M | 4.96M | 4.98M | 949K | 351K | 287K | 206.48K | 93.45K | -99.49K |
Deferred Income Tax | -10.78M | -9.96M | -9.39M | -11.06M | -16.42M | -18.05M | -17.82M | -17.42M | -2.54M | 1.52M | 4.94M | 6.4M | 7.76M | 9.67M | 9.32M | 4.95M | -28.7M | -31.42M |
Change in Working Capital | 30.91M | 32.51M | 30.91M | 34.12M | 4.04M | -20.31M | -37.32M | -34.26M | -19.97M | -3.28M | 13.73M | 8.55M | 5.3M | 3.42M | 5.02M | 1.28M | -8.25M | -6.28M |
Operating Cash Flow | 275.09M | 267.93M | 239.81M | 224.58M | 196.84M | 163.46M | 143.6M | 128.03M | 124.2M | 119.64M | 116.05M | 95.15M | 75.55M | 65.04M | 60.37M | 54.3M | 44.05M | 41.64M |
Capital Expenditures | -373K | -357K | -556K | -36.56M | -115.65M | -115.64M | -115.52M | -80.42M | -11.07M | -11.1M | -11.02M | -10.07M | -138K | -110K | -1.02M | -19.37B | -19.37B | -19.37B |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -13.46M | -13.46M | -13.46M | -23.46M | -10M | -10M | -10M | n/a | n/a | -4M | -10M | -34,725.4B | -34,725.4B | -34,725.4B |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.24M | -9.37M | n/a | n/a | 24.24M | 14.37M | 5M | 5M | 71,969.4B | 71,969.4B | 71,969.4B |
Other Investing Acitivies | n/a | n/a | n/a | -2.23M | -81.51M | -81.51M | -243.81M | -240.92M | -151.77M | -142.4M | 19.9M | 14.24M | 4.37M | -9M | -15M | -9.99M | -19.99M | -15.99M |
Investing Cash Flow | -373K | -357K | -556K | -38.79M | -131.34M | -131.33M | -293.5M | -284.75M | -192.07M | -182.73M | -20.36M | 9.17M | 9.23M | -4.11M | -11.02M | 37,224.6B | 37,224.6B | 37,224.6B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 296K | 296K | n/a | -453K | -749K | -801K | -982K | -739K | -739K | -5.06M | -7.14M | -10.14M | -15.19M | -14.79M | -11.95M | -8.78M | -3.74M | 237K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.04M | -1.76M | -4.47M | -5.14M | -9.29M | -10.66M | -10.86M | -7.94M | 6.17M | 7.75M | 8.6M | 6.9M | 5.87M | 4.76M | 3.95M | 3.42M | 450.54K | 196.53K |
Financial Cash Flow | 2.39M | 2.68M | 140.66M | 135.57M | 131.41M | 130.04M | -10.86M | -7.94M | 6.17M | 3.39M | 1.69M | -3.08M | -9.17M | -9.88M | -8.14M | -5.59M | -2.88M | 863.78K |
Net Cash Flow | 277.11M | 270.25M | 379.92M | 321.36M | 196.91M | 162.16M | -160.76M | -135.09M | -32.13M | -30.13M | 126.95M | 101.23M | 75.62M | 51.04M | 41.21M | 37.73M | 20.24M | 25.58M |
Free Cash Flow | 274.72M | 267.57M | 239.25M | 188.02M | 81.18M | 47.81M | 28.08M | 47.61M | 113.14M | 108.54M | 105.03M | 85.08M | 75.41M | 64.93M | 59.35M | -19.32B | -19.33B | -19.33B |